Larotrectinib: A Targeted Therapy for TRK Fusion Cancer What is Larotrectinib? Larotrectinib is an oral cancer treatment designed to specifically target NTRK gene fusions, a rare genetic abnormality that can…
Ponatinib: Uses, Benefits, Dosage, and Side Effects Ponatinib is a prescription medication used to treat certain types of leukemia. Marketed under the brand name Iclusig, Ponatinib is a tyrosine kinase…
Enasidenib: Uses, Benefits, Dosage & Side Effects Enasidenib (brand name: Idhifa) is an FDA-approved prescription medication used to treat relapsed or refractory acute myeloid leukemia (AML) in adults with an…
Reviews
There are no reviews yet.